Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma
Deletion 17p13, del(17p), is associated with poor outcome in myeloma but some patients show long-term survival. With the current study we intended to identify factors impacting outcome of such high risk patients. We analyzed 110 newly diagnosed, symptomatic patients with del(17p) detected by fluores...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 August 2016
|
| In: |
American journal of hematology
Year: 2016, Jahrgang: 91, Heft: 11, Pages: E473-E477 |
| ISSN: | 1096-8652 |
| DOI: | 10.1002/ajh.24533 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1002/ajh.24533 Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/10.1002/ajh.24533/abstract 
|
| Verfasserangaben: | Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Goldschmidt, Anna Jauch, Jens Hillengass |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1562789643 | ||
| 003 | DE-627 | ||
| 005 | 20220813215649.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170828s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.24533 |2 doi | |
| 035 | |a (DE-627)1562789643 | ||
| 035 | |a (DE-576)492789649 | ||
| 035 | |a (DE-599)BSZ492789649 | ||
| 035 | |a (OCoLC)1340978787 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Merz, Maximilian |d 1985- |e VerfasserIn |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 aut | |
| 245 | 1 | 0 | |a Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma |c Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Goldschmidt, Anna Jauch, Jens Hillengass |
| 264 | 1 | |c 10 August 2016 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.08.2017 | ||
| 520 | |a Deletion 17p13, del(17p), is associated with poor outcome in myeloma but some patients show long-term survival. With the current study we intended to identify factors impacting outcome of such high risk patients. We analyzed 110 newly diagnosed, symptomatic patients with del(17p) detected by fluorescence in situ hybridization (FISH) in CD138-purified myeloma cells to identify prognostic factors for survival. Age >65 years, ISS III, and elevated LDH negatively impacted survival. Patients with subclonal (10-60% of plasma cells) del(17p) had longer progression-free survival (PFS) than patients with del(17p) in >60% of plasma cells (26 vs. 19 months, P = 0.03). Additional gain of 1q21 was associated with shorter PFS (17 vs. 25 months, P = 0.01). Hyperdiploidy did not ameliorate impact of del(17p), but gain 19q13 predicted longer PFS (30 vs. 18 months, P = 0.01) and overall survival (50 vs. 29 months, P = 0.01). Multivariate analysis in transplant eligible patients (≤65 years) revealed better survival for patients treated with upfront autologous transplantation (hazard ratio, [95% confidence interval]: 0.15 [0.04, 0.58], P = 0.006). Application of maintenance therapy was associated with better survival in transplant-eligible patients (0.30 [0.09, 0.99], P = 0.05). We demonstrate heterogeneous outcome of patients with del(17p) according to baseline characteristics and treatment. 19q13 should be included in routine FISH panel, since gains were associated with better survival. Am. J. Hematol. 91:E473-E477, 2016. © 2016 Wiley Periodicals, Inc. | ||
| 700 | 1 | |a Seckinger, Anja |d 1980- |e VerfasserIn |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Mai, Elias K. |d 1985- |e VerfasserIn |0 (DE-588)1049182545 |0 (DE-627)781300274 |0 (DE-576)403130999 |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d New York, NY : Wiley-Liss, 1976 |g 91(2016), 11, Seite E473-E477 |h Online-Ressource |w (DE-627)302923349 |w (DE-600)1492749-4 |w (DE-576)094060002 |x 1096-8652 |7 nnas |a Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma |
| 773 | 1 | 8 | |g volume:91 |g year:2016 |g number:11 |g pages:E473-E477 |g extent:5 |a Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajh.24533 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/10.1002/ajh.24533/abstract |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170828 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 9 |y j | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |e 910000PJ1025525140 |e 911500PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |p 8 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |e 910000PR124052460 |k 0/910000/ |p 6 | ||
| 998 | |g 1049182545 |a Mai, Elias K. |m 1049182545:Mai, Elias K. |d 910000 |d 910100 |e 910000PM1049182545 |e 910100PM1049182545 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |d 50000 |e 910000PH139824995 |e 910100PH139824995 |e 50000PH139824995 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |d 910000 |d 910100 |e 910000PS134177371 |e 910100PS134177371 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 910000 |d 910100 |e 910000PM1023626950 |e 910100PM1023626950 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1562789643 |e 2978647515 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"display":"Merz, Maximilian","family":"Merz","role":"aut","given":"Maximilian"},{"family":"Seckinger","display":"Seckinger, Anja","given":"Anja","role":"aut"},{"role":"aut","given":"Dirk","family":"Hose","display":"Hose, Dirk"},{"given":"Elias K.","role":"aut","family":"Mai","display":"Mai, Elias K."},{"given":"Marc-Steffen","role":"aut","display":"Raab, Marc-Steffen","family":"Raab"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"Anna","role":"aut","display":"Jauch, Anna","family":"Jauch"},{"family":"Hillengaß","display":"Hillengaß, Jens","role":"aut","given":"Jens"}],"id":{"doi":["10.1002/ajh.24533"],"eki":["1562789643"]},"name":{"displayForm":["Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Goldschmidt, Anna Jauch, Jens Hillengass"]},"physDesc":[{"extent":"5 S."}],"recId":"1562789643","relHost":[{"part":{"year":"2016","pages":"E473-E477","issue":"11","text":"91(2016), 11, Seite E473-E477","extent":"5","volume":"91"},"language":["eng"],"id":{"eki":["302923349"],"doi":["10.1002/(ISSN)1096-8652"],"issn":["1096-8652"],"zdb":["1492749-4"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"302923349","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaAmerican journal of hematology","pubHistory":["1.1976 -"],"note":["Gesehen am 19.11.14"],"origin":[{"dateIssuedDisp":"1976-","publisher":"Wiley-Liss","dateIssuedKey":"1976","publisherPlace":"New York, NY"}],"title":[{"title_sort":"American journal of hematology","title":"American journal of hematology"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 28.08.2017"],"origin":[{"dateIssuedDisp":"10 August 2016","dateIssuedKey":"2016"}],"title":[{"title_sort":"Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma","title":"Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma"}]} | ||
| SRT | |a MERZMAXIMIBASELINECH1020 | ||